Moderna Execs Hyped Ineffective RSV Vax, Suit Says

By Julie Manganis · September 24, 2024, 6:15 PM EDT

Officers and directors of Moderna misled investors about the efficacy of its RSV vaccine, causing share prices to dive when it was revealed in June to have only about a 50%...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Ali v. Bancel et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

September 24, 2024

Recent Articles By Julie

October 17, 2024
Ex-Genzyme Exec Says Anxiety Disclosure Led To Firing
October 15, 2024
Motley Rice May Avoid DQ In Boston Opioid Case, Judge Hints
October 10, 2024
Teva To Pay $450M To Settle Kickback Cases
October 08, 2024
Mass. Seeks Order Forcing Steward To Maintain Coverage
September 23, 2024
Mass. General Asks Court To End Fat Removal Patent License
September 18, 2024
Mass. Appeals Court Backs Pot Shop's Arbitration Agreement
September 06, 2024
Abortion Provider Says Activist Group Intercepted Patient Info
August 19, 2024
MOVEit MDL Judge's Call For Order Met With Atty Squabbles
August 05, 2024
CooperSurgical Says Lab Hid Flawed IVF Product Tests
August 01, 2024
AbbVie Wants Mass. Biotech Firm To Pay Up For Drug Work